PL
PL · PL · PL-100345078
Evotaz
ATC J05AR15
Last synced from URPL (Poland) on
Identification
ManufacturerBristol-Myers Squibb Pharma EEIG
CountryPL (PL)
ATC codeJ05AR15
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 2
- gtin05909991224400
- gtin05909991224417
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "300 mg + 150 mg",
"packaging": "05909991224400 ¦ Rpz ¦ EU/1/15/1025/001 ¦ 108689\n30 tabl.\n05909991224417 ¦ Rpz ¦ EU/1/15/1025/002 ¦ 108690\n90 tabl.",
"substance": "Atazanavirum 300 mg + Cobicistatum 150 mg",
"common_name": "Atazanavirum + Cobicistatum",
"pl_product_id": "100345078",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code J05AR15.
- ISEvotazBristol-Myers Squibb Pharma EEIG*
- DKEvotazBristol-Myers Squibb Pharma EEIG
- CZEVOTAZBristol-Myers Squibb Pharma EEIG, Dublin
- FIEVOTAZBristol-Myers Squibb Pharma EEIG
- CZEVOTAZBristol-Myers Squibb Pharma EEIG, Dublin
- BEEvotaz 300 mg - 150 mgBristol-Myers Squibb Pharma
- IEEVOTAZ 300 mg/150 mg film-coated tabletsBristol-Myers Squibb Pharma EEIG
- NLEVOTAZ 300 mg/150 mg filmomhulde tablettenBristol-Myers Squibb Pharma EEIG
Access this data programmatically
Query Evotaz and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.